Open the LID: LXRα regulates ChREBPα transactivity in a target gene-specific manner through an agonist-modulated LBD-LID interaction
Qiong FaniD, Rikke C. Nørgaard, Ivar GrytteniD, Cecilie Maria Ness, Christin Lucas, Kristin Vekterud, Helen M. Soedling, Jason B. MatthewsiD, Roza Berhanu LemmaiD, Odd S. GabrielseniD, Christian BindesbølliD, Stine Marie UlveniD, Hilde Irene NebbiD, Line M. Grønning-Wang, Thomas SætheriD
Abstract
The cholesterol-sensing nuclear receptor liver X receptor (LXR) and the glucose-sensing transcription factor carbohydrate responsive element-binding protein (ChREBP) are central players in regulating glucose and lipid metabolism in liver. We have previously shown that LXR regulates ChREBP transcription and activity; however, the underlying mechanisms are unclear. In the current study, we demonstrate that LXR and ChREBP interact physically, and show a high co-occupancy at regulatory regions in the mouse genome. LXR co-activates ChREBP, and regulates ChREBP-specific target genes in vitro and in vivo. This co-activation is dependent on functional recognition elements for ChREBP, but not for LXR, indicating that ChREBP recruits LXR to chromatin in trans. The two factors interact via their key activation domains; ChREBPs low glucose inhibitory domain (LID) and the ligand-binding domain (LBD) of LXR. While unliganded LXR co-activates ChREBP, ligand-bound LXR surprisingly represses ChREBP activity on ChREBP-specific target genes. Mechanistically, this is due to a destabilized LXR:ChREBP interaction, leading to reduced ChREBP-binding to chromatin and restricted activation of glycolytic and lipogenic target genes. This ligand-driven molecular switch highlights an unappreciated role of LXR that was overlooked due to LXR lipogenesis-promoting function.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 0.46
- Field percentile
- top 38%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pioneer factor Foxa2 enables ligand-dependent activation of LXRα
Jessica Kain, Xiaolong Wei, … Irina M. Bochkis·Molecular MetabolismPeer-reviewed·Jul 8, 2021
- A Novel Mutation in LXRalpha Uncovers a Role for Cholesterol Sensing in Limiting Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Alexis T. Clark, Lillian Russo-Savage, … Ira G. Schulman·Nature CommunicationsPeer-reviewed·Jan 28, 2025
- HGFAC is a ChREBP Regulated Hepatokine that Enhances Glucose and Lipid Homeostasis
A. Sargsyan, L. Doridot, … M. A. Herman·bioRxiv·Jul 29, 2021
- LXR alters CD4+ T cell function through direct regulation of glycosphingolipid synthesis
K. E. Waddington, G. A. Robinson, … I. Pineda-Torra·bioRxiv·Sep 2, 2020
- Liver-specific LXR inhibition represses reverse cholesterol transport in cholesterol-fed mice
T. Nishida, M. Ayaori, … K. Ikewaki·AtherosclerosisPeer-reviewed·Oct 1, 2024
- 4 β-hydroxycholesterol is a pro-lipogenic factor that promotes SREBP1c expression and activity through Liver X-receptor.
O. Moldavski, P.-J. H. Zushin, … R. Zoncu·bioRxiv·Aug 20, 2020